• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇负载壳聚糖膜植入小鼠后的体外特性研究。

An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice.

作者信息

Panchagnula Ramesh, Dhanikula Renu Singh, Dhanikula Anand Babu

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, S.A.S Nagar (Punjab),160062, India.

出版信息

Curr Drug Deliv. 2006 Jul;3(3):287-97. doi: 10.2174/156720106777731028.

DOI:10.2174/156720106777731028
PMID:16848730
Abstract

The objective of present investigation was the characterization of chitosan films after in vivo implantation. Chitosan films were prepared at three dose loadings of paclitaxel by classical casting method. They were implanted subcutaneously in Swiss mice in the neck region and were removed at 7, 15, 21 and 30 days post implantation for characterization. In vitro release studies on explanted films were done to observe the influence of the time of implantation and loading on paclitaxel release, which were correlated with amount of paclitaxel remaining in films. Residual amount of paclitaxel remaining in explanted films decreased with increase in loading i.e. after 30 days, the % residual content of drug at 25, 20 and 15 mg loadings (per film) were 13, 20 and 45 % of the initial loading. The in vivo release of paclitaxel from films with higher loadings was higher, indicating that paclitaxel, per se, altered biodegradation of chitosan. Light microscopy and SEM studies of films removed from mice provided qualitative information on the loss of integrity and biodegradation of films with time. Further, FTIR and ATR-FTIR spectra revealed the changes in the film matrix that occur after implantation.

摘要

本研究的目的是对壳聚糖膜在体内植入后的特性进行表征。采用经典流延法制备了三种紫杉醇剂量负载的壳聚糖膜。将它们皮下植入瑞士小鼠的颈部区域,并在植入后7、15、21和30天取出进行表征。对取出的膜进行体外释放研究,以观察植入时间和负载量对紫杉醇释放的影响,并将其与膜中剩余紫杉醇的量相关联。取出的膜中紫杉醇的残留量随负载量的增加而降低,即30天后,25、20和15mg负载量(每片)的药物残留百分比分别为初始负载量的13%、20%和45%。高负载量膜中紫杉醇的体内释放量更高,表明紫杉醇本身改变了壳聚糖的生物降解。对从小鼠体内取出的膜进行光学显微镜和扫描电子显微镜研究,提供了膜完整性丧失和随时间生物降解的定性信息。此外,傅里叶变换红外光谱和衰减全反射傅里叶变换红外光谱揭示了植入后膜基质的变化。

相似文献

1
An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice.紫杉醇负载壳聚糖膜植入小鼠后的体外特性研究。
Curr Drug Deliv. 2006 Jul;3(3):287-97. doi: 10.2174/156720106777731028.
2
[Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].[载紫杉醇壳聚糖聚合物胶束的制备及其表面电荷对小鼠体内组织生物分布的影响]
Yao Xue Xue Bao. 2006 Sep;41(9):867-72.
3
Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.基于泊洛沙姆 407 的温敏性胶束-水凝胶杂化系统用于紫杉醇的局部递送。
J Pharm Sci. 2013 Aug;102(8):2707-17. doi: 10.1002/jps.23649. Epub 2013 Jul 9.
4
Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ϵ-caprolactone) films.将紫杉醇固体分散体与泊洛沙姆 188 或聚乙二醇结合,从聚(ε-己内酯)薄膜中调节药物释放。
Drug Dev Ind Pharm. 2013 Aug;39(8):1187-96. doi: 10.3109/03639045.2012.704042. Epub 2012 Jul 17.
5
Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.载紫杉醇的 Pluronic 纳米粒经壳聚糖/肝素复合修饰后靶向能力增强。
Mol Pharm. 2012 Feb 6;9(2):230-6. doi: 10.1021/mp200278s. Epub 2011 Dec 23.
6
Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.部分水解乙烯-醋酸乙烯共聚物薄膜的制备、表征及控释药物性能研究。
Int J Pharm. 2010 Nov 15;400(1-2):66-73. doi: 10.1016/j.ijpharm.2010.08.031. Epub 2010 Sep 8.
7
In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.一种用于紫杉醇持续递送的新型生物相容性聚合物-脂质植入系统的体外和体内特性研究
J Control Release. 2005 May 5;104(1):181-91. doi: 10.1016/j.jconrel.2005.02.008. Epub 2005 Mar 23.
8
In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.紫杉醇局部和全身给药替代制剂(凝胶、薄膜、前药、脂质体和胶束)在小鼠体内的药代动力学和组织分布研究
Curr Drug Deliv. 2005 Jan;2(1):35-44. doi: 10.2174/1567201052772852.
9
Paclitaxel Loaded Nanoliposomes in Thermosensitive Hydrogel: A Dual Approach for Sustained and Localized Delivery.热敏水凝胶中负载紫杉醇的纳米脂质体:一种实现持续和局部递送的双重方法
Anticancer Agents Med Chem. 2016;16(3):365-76. doi: 10.2174/1871520615666150807103910.
10
α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.α-生育酚琥珀酸酯修饰壳聚糖作为紫杉醇的胶束递送系统:制备、表征及体内外评价。
Int J Pharm. 2012 Feb 28;423(2):480-8. doi: 10.1016/j.ijpharm.2011.12.004. Epub 2011 Dec 13.

引用本文的文献

1
Innovative landscapes in intraperitoneal therapy of ovarian cancer.卵巢癌腹腔内治疗的创新前景。
Drug Deliv Transl Res. 2025 Jun;15(6):1877-1906. doi: 10.1007/s13346-024-01765-w. Epub 2025 Jan 31.